Predisposition Biomarkers Market Size

Predisposition Biomarkers Market size is expected to register remarkable growth rate during the forecast period i.e., between 2024-2036.

The growth of the market can be attributed to the various advantages provided by biomarkers in reducing and monitoring the risks of several acute and chronic disease, along with aid in diagnosis and treatment. The use of biomarkers, significantly reduces the healthcare expenditure, as it monitors the health beforehand, which is estimated to boost its demand throughout the forecast period. Moreover, the rising prevalence of diseases, such as, cancer, and diabetes along with increasing government initiatives to reduce the cases of such diseases, is anticipated to promote the market growth. According to the data by the WHO, over 422 million people around the world suffer from diabetes, and it causes about 1.6 million deaths every year. Furthermore, introduction of novel and advanced technologies, such as, digital biomarkers, and escalating adoption of personalized medicines is projected to boost the market growth.